Pangenomic Health IncCanadian Securities Exchange:NARA
- LAST PRICE0.1500
- TODAY'S CHANGE (%)0.0700 (87.5000%)
- Bid / Lots0.0800/ 2
- Ask / Lots0.2500/ 3
- Open / Previous Close0.0900 / 0.0800
- Day Range
- 52 Week Range
- Volume12,280
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NARA |
|---|---|---|
| 01:40 ET | 1000 | 0.09 |
| 01:42 ET | 6000 | 0.1 |
| 03:08 ET | 3000 | 0.15 |
Nov 7, 2024
PanGenomic Health Announces Proposed Consolidation, from 9:01PM ET on Thursday Nov 07, 2024 by Dow Jones
9:01PM ET on Thursday Nov 07, 2024 by Dow Jones
Oct 31, 2024
PanGenomic Health Announces AGM Results, from 6:31PM ET on Thursday Oct 31, 2024 by Dow Jones
6:31PM ET on Thursday Oct 31, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Pangenomic Health Inc | 2.6M | -0.4x | --- |
EvokAI Creative Labs Inc | 2.3M | -0.2x | --- |
Izotropic Corp | 3.4M | -1.2x | --- |
Binovi Technologies Corp | 2.3M | 0.0x | --- |
Verisante Technology Inc | 659.1K | -4.9x | --- |
Cognetivity Neurosciences Ltd | 887.2K | -0.1x | --- |
Company Information
Pangenomic Health Inc. is a precision health company. The Company has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Its products include a mobile app for consumers (Nara), a telehealth mental health app and telehealth platform for consumers (Mindleap) and a clinical decision support platform for health practitioners (MUJN). The Nara mobile app provides consumers with a knowledge base, which is based on individual's user profile, leveraging input from mental health questionnaires, drug treatment regimen, genomic sequencing analysis, as well as their protein and microbiome biomarker reports. The Mindleap platform provides a variety of tools and resources to help individuals understand and improve their inner wellness. The MUJN clinical decision support platform provides health practitioners with access to the consumer's mobile app data and their diagnostic reports.
Contact Information
- Headquarters
- 102 3800 Wesbrook MallVANCOUVER, BC, Canada V6S 2L9
- Phone
- 778-743-4642
- Fax
- 604-688-9588
Executives
- Executive Chairman of the Board
- Robert Nygren
- President, Chief Executive Officer, Director
- Maryam Marissen
- Chief Financial Officer, Treasurer, Secretary
- Tammy Gillis
- Director
- Francisco Carasquero
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.6M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 32.0M |
Pangenomic Health Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.36 |
Book Value | $-0.20 |
P/E Ratio | -0.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
